The simultaneous $4M open-market buys by a director and a 10% owner signal strong confidence in ALMR's valuation at $17/share. While non-cash derivative activity dominates the cluster, the cash purchases are material and concentrated. Traders should watch for follow-up commentary or filings that may explain the catalyst behind this rare dual insider buy-in.
Price Chart
Executive Summary
Two insiders at Alamar Biosciences, Inc. (ALMR) — Director Nicholas Naclerio and 10% owner Illumina Innovation Fund II GP, L.L.C. — each purchased 235,294 shares in open-market transactions on April 20, 2026, for a combined $8.0 million. These are the only cash transactions in a broader cluster of non-cash derivative conversions and share adjustments.
Key Financial Metrics
Key Facts
- Director Nicholas Naclerio and 10% owner Illumina Innovation Fund II GP, L.L.C. each bought 235,294 shares at $17 per share, totaling $4.0 million each.
- Total open-market purchases in the cluster: $8.0 million.
- All other transactions in the cluster were non-cash (derivative conversions, grants, or other adjustments), totaling no economic value.
- The purchases occurred on the same day, indicating coordinated confidence.
- No C-suite executives other than the CFO and CEO (who only had non-cash events) participated in cash transactions.
Financial Impact
$8.0 million in open-market purchases at $17 per share
Risk Factors
- The majority of transactions are non-cash and do not reflect economic investment.
- No C-suite executives (other than the CEO and CFO, who had no cash trades) participated in the buying.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALMR-1776732357349 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.69 (−11.93%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.69 (−11.93%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.69 (+11.93%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.69 (−4.87%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.69 (−6.43%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.69 (+0.66%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.69 (−16.08%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.69 (+12.01%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.69 (+7.99%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.69 (+28.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers